SLG
BSX icon

Stanley-Laman Group’s Boston Scientific BSX Stock Holding History

Stanley-Laman Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,763
Closed -$173K – 303
2026
Q1 		$173K Buy
2,763
+263
+11% +$21K 0.02% 282
2025
Q4 		$238K Hold
2,500
– – 0.03% 266
2025
Q3 		$244K Hold
2,500
– – 0.03% 239
2025
Q2 		$269K Hold
2,500
– – 0.04% 250
2025
Q1 		$252K Hold
2,500
– – 0.04% 250
2024
Q4 		$223K Hold
2,500
– – 0.03% 268
2024
Q3 		$210K Buy
+2,500
New +$197K 0.03% 280
2016
Q1 		– Sell
-44,231
Closed -$816K – 299
2015
Q4 		$816K Buy
+44,231
New +$793K 0.14% 170

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Stanley-Laman Group's BSX Position: Q2 2026 in Review

Stanley-Laman Group sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 2,763 shares — an estimated $173K sold.

Stanley-Laman Group first reported a position in BSX in Q4 2015 and held it in 8 quarters. The position peaked at $816K in Q4 2015. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Stanley-Laman Group reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Stanley-Laman Group sold 2,763 Boston Scientific shares in Q2 2026, an estimated $173K.
  • Stanley-Laman Group first reported a position in Boston Scientific in Q4 2015 and held it in 8 quarters.
  • Stanley-Laman Group's Boston Scientific position peaked at $816K in Q4 2015.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Stanley-Laman Group's 13F filing for Q2 2026, filed 5 Aug 2026.